Patient-Informed Treatment Development of Behavioral Smoking Cessation for People With Schizophrenia.

Published

Journal Article

The objective of this study was to use qualitative methodology to tailor and refine an existing smoking cessation intervention for the population of people who use cigarettes and are diagnosed with schizophrenia, schizoaffective, or psychotic disorder. Successive cohort design methodology was used to iteratively modify the treatment in response to qualitative participant, therapist, and consultant feedback on the intervention. Qualitative methodology for participant feedback included analysis of semistructured interviews with participants, visualization of app utilization data, and stakeholder feedback from study therapists and consultants. Using the successive cohort design, a tailored multicomponent mobile health smoking cessation intervention was developed. The intervention included mobile contingency management (i.e., financial compensation for confirmed abstinence from smoking), pharmacotherapy for smoking cessation, cognitive-behavioral counseling sessions, and the Stay Quit app for relapse prevention. Two cohorts (N = 13) were completed in the study; after each cohort, the treatment protocol was revised. The intervention is described, as well as the qualitative findings from each cohort and subsequent changes made to the intervention based upon patient and provider feedback. Metrics of patient engagement included treatment adherence (40% in Cohort 1 and 63% in Cohort 2). Both participants and therapists reported that the intervention was helpful. Over one third of participants self-reported abstinence at posttreatment. Since qualitative methodology is often underutilized in mental health treatment development, this study demonstrates the utility of the successive cohort design for treatment development of behavior change interventions for at-risk, vulnerable populations.

Full Text

Duke Authors

Cited Authors

  • Wilson, SM; Thompson, AC; Currence, ED; Thomas, SP; Dedert, EA; Kirby, AC; Elbogen, EB; Moore, SD; Calhoun, PS; Beckham, JC

Published Date

  • March 2019

Published In

Volume / Issue

  • 50 / 2

Start / End Page

  • 395 - 409

PubMed ID

  • 30824254

Pubmed Central ID

  • 30824254

Electronic International Standard Serial Number (EISSN)

  • 1878-1888

Digital Object Identifier (DOI)

  • 10.1016/j.beth.2018.07.004

Language

  • eng

Conference Location

  • England